John Drayton Wise Insmed Inc (INSM) insider trading activity

INSM Quotes by TradingView

John Drayton Wise is Chief Commercial Officer of INSMED Inc. Currently has a direct ownership of 125,562 shares of INSM, which is worth approximately $8.25 Million. The most recent transaction as insider was on Jan 10, 2025, when has been sold 287 shares (Common Stock) at a price of $65.4 per share, resulting in proceeds of $18,769. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 126K
3.21% 3M change
10.31% 12M change
Total Value Held $8.25 Million

John Drayton Wise Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 10 2025
SELL
Open market or private sale
$18,769 $65.4 p/Share
287 Reduced 0.23%
125,562 Common Stock
Jan 08 2025
SELL
Open market or private sale
$25,954 $66.21 p/Share
392 Reduced 0.33%
119,192 Common Stock
Jan 08 2025
BUY
Grant, award, or other acquisition
-
6,657 Added 5.02%
125,849 Common Stock
Jan 07 2025
SELL
Open market or private sale
$851,024 $65.93 p/Share
12,908 Reduced 9.74%
119,584 Common Stock
Jan 07 2025
BUY
Exercise of conversion of derivative security
$160,700 $16.07 p/Share
10,000 Added 7.02%
132,492 Common Stock
May 28 2024
SELL
Open market or private sale
$388,516 $49.48 p/Share
7,852 Reduced 6.06%
121,657 Common Stock
May 28 2024
BUY
Exercise of conversion of derivative security
$78,625 $12.58 p/Share
6,250 Added 4.66%
127,907 Common Stock
May 14 2024
SELL
Open market or private sale
$129,591 $25.47 p/Share
5,088 Reduced 3.96%
123,259 Common Stock
May 13 2024
BUY
Grant, award, or other acquisition
-
14,518 Added 10.16%
128,347 Common Stock
Jan 09 2024
SELL
Open market or private sale
$53,559 $28.78 p/Share
1,861 Reduced 1.61%
113,829 Common Stock
Jan 05 2024
SELL
Open market or private sale
$34,216 $29.32 p/Share
1,167 Reduced 1.0%
115,690 Common Stock
Jan 04 2024
BUY
Grant, award, or other acquisition
-
12,873 Added 9.92%
116,857 Common Stock
Jan 03 2024
SELL
Open market or private sale
$585,872 $29.19 p/Share
20,071 Reduced 16.18%
103,984 Stock Option (Right to...
Jan 03 2024
BUY
Exercise of conversion of derivative security
$383,556 $19.11 p/Share
20,071 Added 13.93%
124,055 Stock Option (Right to...
May 25 2023
SELL
Open market or private sale
$63,785 $18.95 p/Share
3,366 Reduced 3.17%
102,681 Common Stock
May 17 2023
SELL
Open market or private sale
$34,759 $18.17 p/Share
1,913 Reduced 1.77%
106,047 Common Stock
May 16 2023
SELL
Open market or private sale
$7,025 $18.44 p/Share
381 Reduced 0.35%
107,960 Common Stock
May 15 2023
SELL
Open market or private sale
$11,438 $19.29 p/Share
593 Reduced 0.54%
108,341 Common Stock
May 11 2023
BUY
Grant, award, or other acquisition
-
31,662 Added 22.52%
108,934 Common Stock
Jan 10 2023
SELL
Open market or private sale
$13,990 $17.96 p/Share
779 Reduced 1.0%
77,272 Common Stock
Jan 05 2023
SELL
Open market or private sale
$22,898 $19.74 p/Share
1,160 Reduced 1.62%
70,453 Common Stock
Jan 05 2023
BUY
Grant, award, or other acquisition
-
7,598 Added 8.87%
78,051 Common Stock
Nov 22 2022
SELL
Open market or private sale
$134,781 $18.84 p/Share
7,154 Reduced 9.08%
71,613 Common Stock
Aug 10 2022
SELL
Open market or private sale
$7,170 $27.79 p/Share
258 Reduced 0.33%
78,767 Common Stock
May 23 2022
BUY
Grant, award, or other acquisition
-
26,236 Added 25.14%
78,137 Common Stock
JDW

John Drayton Wise

Chief Commercial Officer
Bridgewater, NJ

Track Institutional and Insider Activities on INSM

Follow INSMED Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INSM shares.

Notify only if

Insider Trading

Get notified when an Insmed Inc insider buys or sells INSM shares.

Notify only if

News

Receive news related to INSMED Inc

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on INSM